ro-3306 and Gastrointestinal-Stromal-Tumors

ro-3306 has been researched along with Gastrointestinal-Stromal-Tumors* in 1 studies

Other Studies

1 other study(ies) available for ro-3306 and Gastrointestinal-Stromal-Tumors

Article	Year
Integrated Screens Identify CDK1 as a Therapeutic Target in Advanced Gastrointestinal Stromal Tumors. Cancer research, 2021, 05-01, Volume: 81, Issue:9 Topics: Adult; Aged; Animals; Antineoplastic Agents; CDC2 Protein Kinase; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cohort Studies; Drug Resistance, Neoplasm; Female; Gastrointestinal Stromal Tumors; HEK293 Cells; Humans; Imatinib Mesylate; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Protein Kinase Inhibitors; Quinolines; Thiazoles; Transfection; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays	2021

Article

Year

Integrated Screens Identify CDK1 as a Therapeutic Target in Advanced Gastrointestinal Stromal Tumors.

Cancer research, 2021, 05-01, Volume: 81, Issue:9

Topics: Adult; Aged; Animals; Antineoplastic Agents; CDC2 Protein Kinase; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cohort Studies; Drug Resistance, Neoplasm; Female; Gastrointestinal Stromal Tumors; HEK293 Cells; Humans; Imatinib Mesylate; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Protein Kinase Inhibitors; Quinolines; Thiazoles; Transfection; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays

2021